![Peter B. Heifetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter B. Heifetz
Directeur Général chez
OrPro Therapeutics, Inc.
Profil
Peter B. Heifetz is currently the President, Chief Executive Officer & Director at OrPro Therapeutics, Inc. and the Chief Scientific Officer at Rincon Pharmaceuticals, Inc. He holds graduate and doctorate degrees from Duke University.
Postes actifs de Peter B. Heifetz
| Sociétés | Poste | Début |
|---|---|---|
OrPro Therapeutics, Inc.
 OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures recombinant thioredoxin for the treatment of cystic fibrosis | Directeur Général | - |
Anciens postes connus de Peter B. Heifetz
| Sociétés | Poste | Fin |
|---|---|---|
Rincon Pharmaceuticals, Inc.
 Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops human therapeutic proteins | Directeur Technique/Scientifique/R&D | - |
Formation de Peter B. Heifetz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Rincon Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops human therapeutic proteins | Health Technology |
OrPro Therapeutics, Inc.
OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures recombinant thioredoxin for the treatment of cystic fibrosis | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
